Initial clinical data for BDC-4182 Phase 1 dose escalation study expected in 3Q 2026  Cash balance of $38.8 million as of September 30, 2025 anticipated to fund key milestones into 2027 REDWOOD CITY, ...

Bo_RC_25 validates and expands the ultra high-grade zone first identified in Bo_RC_14 (Released Sept. 4), reinforcing ...